{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Astrazeneca Ab", "item": "https://www.patentleaderboard.com/company/astrazeneca-ab"}, {"@type": "ListItem", "position": 3, "name": "Scott Boyd", "item": "https://www.patentleaderboard.com/inventor/fl:sc_ln:boyd-7"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
SB

Scott Boyd — 4 Patents

Astrazeneca Ab: 4 patents #334 of 1,971Top 20%
Cambridge, GB: #1,207 of 4,587 inventorsTop 30%
Overall (All Time): #1,080,739 of 4,157,543Top 30%
4 Patents All Time
Scott Boyd has been granted 4 US patents while listed as an inventor at Astrazeneca Ab. The first was granted in 2008 and the most recent in September 2025. Scott Boyd ranks #1,080,739 of 4,157,543 US inventors in our database (top 26.0%). Patent records list Scott Boyd in Cambridge, GB.

Patents per Year

Patents granted per year, 2008 to 2025Bar chart with a peak of 1 patents in 2008.peak 12008: 1 patents20082009: 1 patents20092011: 1 patents20112025: 1 patents2025

Issued Patents All Time

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
12410187 Fused tricyclic compounds useful as anticancer agents Jason Grant Kettle, Iain Simpson, Christopher Phillips, Oliver Ross Steward, Michael Steven Bodnarchuk +2 more 2025-09-09
7951830 Compounds effecting glucokinase Peter William Rodney Caulkett, Rodney B. Hargreaves, Suzanne Saxon Bowker, Roger James, Clifford David Jones +3 more 2011-05-31 $9,019,000
7524957 Compounds effecting glucokinase Peter William Rodney Caulkett, Rodney B. Hargreaves, Suzanne Saxon Bowker, Roger James, Clifford David Jones +3 more 2009-04-28 $7,591,000
7390908 Compounds effecting glucokinase Peter William Rodney Caulkett, Rodney B. Hargreaves, Suzanne Saxon Bowker, Roger James, Craig Johnstone +3 more 2008-06-24 $34,857,000